Abbott Scores $760M US Gov Deal For Rapid Covid-19 Saliva Test
Oh inflation, where art thou
Bad Monetary Theory Enables Disastrous Government Policies
Asia equities lower ahead of Powell speech
May the salesforce be with you
Schiff: Government Is Trying To Replace The Economy With A Printing Press
NZ Dollar Firm amid Positive Market Sentiment, Ignores Historic Drop of Retail Sales Values
Novavax starts enrollment for phase two of Covid-19 vaccine trial
AstraZeneca Rises On Report Trump Could Fast-Track Covid-19 Vaccine Candidate
AstraZeneca Receives Russian Nod For Covid-19 Vaccine Trial- Report
Trump Considers Fast-Tracking AstraZeneca Covid Vaccine Ahead Of Elections
"If You're Reading This, You Might Be A Conspiracy Theorist..."
Herd immunity is not a number (part 2)
Regeneron recruits Roche to make COVID-19 antibody drug REGN-COV2
U.S. to let pharmacists vaccinate kids as lockdowns slash immunization levels
Australia Inks Deal With AstraZeneca For Supply Of Covid-19 Vaccine Candidate
The dollar has left the building
Moderna’s COVID-19 Vaccine’s Pricing Disappoints Investors, But This Analyst Remains With the Bulls
"Massively Compromised" - Corporate Debt Issuance Soars To Record Highs
Precious metals climb, oil stays range-bound
I’m all about that yield, ’bout that yield
What Difference Does It Make?
Kiadis shares yo-yo on cell therapy trial for COVID-19
Innovator extends defined-outcome strategy to bond ETFs
This Is One Of The Single Biggest Threats To The Dollar Today
AstraZeneca Clinches First Supply Deal With EU For Covid-19 Vaccine
Covid-19 vaccine makers must hit U.S. timing goals for full payments
Novavax Pops 7% On South Korea Deal For Global Covid-19 Vaccine Supply
Fixed income drove ETP buying in July
Novavax Inks UK Supply Deal For 60M Doses Of Its Covid-19 Vaccine Candidate